Secernin-1 level in urine has not been detected by MRM-MS thus far, so the potential of secernin-1 as a noninvasively obtained biomarker candidate in urine from prostate cancer patients is still part of our ongoing work. This evidence concerns the gene SCRN1 and Familial prostate cancer.